Related Experiment Video

Updated: May 19, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

SHP-2 phosphatase promotes cervical cancer cell proliferation through inhibiting interferon-β production

Fei Meng1, Xiaoyun Zhao, Shulan Zhang

  • 1Department of Obstetrics and Gynecology, Shengjing Hospital, China Medical University Department of Microbiology and Cell Biology, School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, Liaoning Province, China.

The Journal of Obstetrics and Gynaecology Research
|August 15, 2012
PubMed
Abstract

Insights

Src-homology-2-domain-containing protein, tyrosine phosphatase 2 (SHP-2) promotes cervical cancer cell growth by suppressing interferon-beta (IFN-β) production. Inhibiting SHP-2 may offer a therapeutic strategy for cervical cancer.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Cervical cancer is a significant global health concern.
  • The role of specific protein tyrosine phosphatases, like SHP-2, in cervical cancer progression is not fully understood.
  • Interferon-beta (IFN-β) is a key cytokine involved in immune responses and tumor suppression.

Purpose of the Study:

  • To investigate the effect of Src-homology-2-domain-containing protein, tyrosine phosphatase 2 (SHP-2) on cervical cancer cell proliferation.
  • To determine the relationship between SHP-2 expression and IFN-β levels in cervical tissues.
  • To elucidate the mechanism by which SHP-2 influences cervical cancer cell growth and IFN-β production.

Main Methods:

  • Immunohistochemistry was used to assess SHP-2 and IFN-β expression in patient tissues (cervical cancer, CIN, healthy controls).
  • SHP-2 expression was knocked down using siRNA or blocked with a specific peptide in THP-1 cells.
  • Co-culture assays with SiHa cells, MTT assays, and ELISA were employed to evaluate cell proliferation and IFN-β production.

Main Results:

  • SHP-2 expression was significantly elevated in cervical cancer tissues compared to CIN and uterine myoma tissues.
  • SHP-2 levels negatively correlated with IFN-β expression in cervical tissues.
  • SHP-2 knockdown or blockade in THP-1 cells led to increased IFN-β production and inhibited SiHa cell proliferation.

Conclusions:

  • SHP-2 phosphatase activity promotes cervical cancer cell proliferation.
  • The mechanism involves the inhibition of interferon-beta (IFN-β) production by SHP-2.
  • Targeting SHP-2 may represent a novel therapeutic approach for cervical cancer.

More Related Videos

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis07:26

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis

Published on: January 31, 2025

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...